Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 5, 2002, Pages 1331-1335

  Rodrigues, Neesha ^a   Carter, Darryl ^a   Dillon, Deborah ^a   Parisot, Nicole ^a   Choi, Doo Ho ^a   Haffty, Bruce G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast conserving therapy; Local relapse; Necrosis; Prognostic factors

Indexed keywords

MAMMOGRAPHY; PATHOLOGY; RADIOTHERAPY; SURGERY; TUMORS;

HORMONAL THERAPY;

ONCOLOGY;

TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCT; BREAST NECROSIS; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RECURRENCE; CARCINOMA IN SITU; CLINICAL FEATURE; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; FAMILY HISTORY; FOLLOW UP; HISTOLOGY; HUMAN; INFORMATION PROCESSING; LOCAL THERAPY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NECROSIS; PROGNOSIS; RECURRENCE; TAMOXIFEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036891094     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03747-1     Document Type: Article

References (17)

1. Schwartz G.F., Solin L.J., Olivotto I.A., et al. Consensus conference on the treatment of in situ ductal carcinoma of the breast. April 22-25, 1999 Cancer. 88:2000;946-954.
2. Fisher E.R., Dignam J., Tan-Chiu E., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Eight-year update of protocol B-17. Cancer. 86:1999;429-438.
3. Fisher E.R., Costantino J., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Cancer. 75:1995;1310-1319.
4. McCormick B., Rosen P.P., Kinne D., et al. Duct carcinoma in situ of the breast An analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 231:1991;289-292.
5. Solin L.J., Yeh I., Kurtz J., et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Cancer. 71:1993;2532-2542.
6. Vicini F.A., Lacerna M.D., Goldstein N.S., et al. Ductal carcinoma in situ detected in the mammographic era An analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 39:1997;627-635.
7. VanZee K.J., Liberman L., Samli B., et al. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery The effect of age. Cancer. 86:1999;1757-1767.
8. Kestin L.L., Goldstein N.S., Martinez A.A., et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy. Ann Surg. 231:2000;235-245.
9. Vicini F.A., Kestin L.L., Goldstein N.S., et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol. 18:2000;296-306.
10. Solin L.J., Fourquet A., Vicini F.A., et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation Long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys. 50:2001;991-1002.
11. Bornstein B.A., Recht A., Connolly J.L., et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer. 67:1991;7-13.
12. Solin L.J., Kurtz J., Fourquet A., et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol. 14:1996;754-763.
13. Kestin L.L., Goldstein N.S., Lacerna M.D., et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer. 88:2000;596-607.
14. Silverstein M.J., Waisman J.R., Gamagami P., et al. Intraductal carcinoma of the breast (208 cases) Clinical factors influencing treatment choice. Cancer. 66:1990;102-108.
15. Silverstein M.J., Cohlan B.F., Gierson E.D., et al. Duct carcinoma in situ 227 cases without microinvasion. Eur J Cancer. 28:1992;630-634.
16. Recht A., Silver B., Schnitt S., et al. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency, and salvage. Int J Radiat Oncol Biol Phys. 11:1985;1271-1276.
17. Fisher B., Dignam J., Wolmark N., et al. Tamoxifen in treatment of intraductal breast cancer National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 353:1999;1993-2000.